Novel antimicrobial catheter lock solution: A new direction in which chelators replace heparin

Critical Care Medicine

Volumn 39, Issue 4, 2011, Pages 875-876

  Raad, Issam ^a   Bodey, Gerald P ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

catheter related bloodstream infection; central venous catheter; chelators; hemodialysis catheter; lock solution

Indexed keywords

ANTIMICROBIAL LOCK SOLUTION; CHELATING AGENT; CITRATE SODIUM; EDETIC ACID; HEPARIN; METHYLENE BLUE; MINOCYCLINE; MISCELLANEOUS DRUGS AND AGENTS; TAUROLIDINE; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; BIOFILM; CATHETER; CATHETER INFECTION; EDITORIAL; HEMODIALYSIS PATIENT; HUMAN; IN VITRO STUDY; INFECTION CONTROL; MICROBIAL COLONIZATION; MORTALITY; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; THROMBOCYTOPENIA; THROMBOSIS;

EID: 79953206285     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31820e4474     Document Type: Editorial

References (25)

1. Maki DG, Ash SR, Winger RK, et al: A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: A multicenter, controlled, randomized trial. Crit Care Med 2011; 39:613-620.
2. Raad I, Hachem R, Tcholakian RK, et al: Efficacy of minocycline and EDTA lock solution in preventing catheter-related bacteremia, septic phlebitis, and endocarditis in rabbits. Antimicrob Agents Chemother 2002; 46: 327-332. (Pubitemid 34087176)
3. Shanks RM, Donegan NP, Graber ML, et al: Heparin stimulates Staphylococcus aureus biofilm formation. Infect Immun 2005; 73: 4596-4606. (Pubitemid 41105614)
4. Shanks RM, Sargent JL, Martinez RM, et al: Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces. Nephrol Dial Transplant 2006; 21:2247-2255. (Pubitemid 44295052)
5. Blossom D, Noble-Wang J, Su J, et al: Multistate outbreak of Serratia marcescens bloodstream infections caused by contamination of prefilled heparin and isotonic sodium chloride solution syringes. Arch Intern Med 2009; 169:1705-1711.
6. Moritz ML, Vats A, Ellis D: Systemic anticoagulation and bleeding in children with hemodialysis catheters. Pediatr Nephrol 2003; 18:68-70. (Pubitemid 36798477)
7. Yevzlin A, Sanchez R, Hiatt J, et al: Concentrated heparin lock is associated with major bleeding complications after tunneled hemodialysis catheter placement. Semin Dial 2007; 20:351-354.
8. Yamamoto S, Koide M, Matsuo M, et al: Heparin-induced thrombocytopenia in hemodialysis patients. Am J Kidney Dis 1996; 28: 82-85. (Pubitemid 26231470)
9. Murray PT, Hursting MJ: Heparin-induced thrombocytopenia in patients administered heparin solely for hemodialysis. Ren Fail 2006; 28:537-539. (Pubitemid 44581932)
10. Pena De la Vega L, Miller RS, Benda MM, et al: Association of heparin-dependent antibodies and adverse outcomes in hemodialysis patients: A population-based study. Mayo Clin Proc 2005; 80:995-1000. (Pubitemid 41099384)
11. Stribling WK, Slaughter TF, Houle TT, et al: Beyond the platelet count: Heparin antibodies as independent risk predictors. Am Heart J 2007; 153:900-906. (Pubitemid 46809845)
12. Buturovic-Ponikvar J, Gubensek J, Ponikvar R: Citrate anticoagulation for single-needle hemodialysis: Safety and efficacy. Ther Apher Dial 2005; 9:237-240. (Pubitemid 41099507)
13. Reardon DM, Warner B, Trowbridge EA: EDTA, the traditional anticoagulant of haematology: With increased automation is it time for a review? Med Lab Sci 1991; 48: 72-75.
14. Raad II, Fang X, Keutgen XM, et al: The role of chelators in preventing biofilm formation and catheter-related bloodstream infections. Curr Opin Infect Dis 2008; 21:385-392.
15. Patrauchan MA, Sarkisova S, Sauer K, et al: Calcium influences cellular and extracellular product formation during biofilm-associated growth of a marine Pseudoalteromonas sp. Microbiology 2005; 151:2885-2897. (Pubitemid 41319443)
16. Percival SL, Kite P, Eastwood K, et al: Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infect Control Hosp Epidemiol 2005; 26:515-519. (Pubitemid 40896140)
17. Raad I, Chatzinikolaou I, Chaiban G, et al: In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces. Antimicrob Agents Chemother 2003; 47:3580-3585. (Pubitemid 37345723)
18. Takla TA, Zelenitsky SA, Vercaigne LM: Effectiveness of a 30% ethanol/4% trisodium citrate locking solution in preventing biofilm formation by organisms causing haemodialysis catheter-related infections. J Antimicrob Chemother 2008; 62:1024-1026.
19. Bleyer AJ, Mason L, Russell G, et al: A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. Infect Control Hosp Epidemiol 2005; 26:520-524. (Pubitemid 40896141)
20. Chatzinikolaou I, Zipf TF, Hanna H, et al: Minocycline- ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer. Clin Infect Dis 2003; 36:116-119. (Pubitemid 36099107)
21. McGovern P, Compher C, Evans-Stoner N, et al: Minocycline-disodium EDTA lock solution in a long-term parenteral nutrition population [Abstract]. In: The 16th Annual Scientific Meeting of the Society for Healthcare and Epidemiology of America 2006; March 18-21; Chicago, IL.
22. Raad I, Buzaid A, Rhyne J, et al: Minocycline and ethylenediaminetetraacetate for the prevention of recurrent vascular catheter infections. Clin Infect Dis 1997; 25:149-151. (Pubitemid 27293088)
23. Allon M: Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis 2003; 36:1539-1544. (Pubitemid 36783336)
24. Betjes MG, Van Agteren M: Prevention of dialysis catheter-related sepsis with a citratetaurolidine-containing lock solution. Nephrol Dial Transplant 2004; 19:1546-1551. (Pubitemid 38786749)
25. Sauer K, Steczko J, Ash SR: Effect of a solution containing citrate/methylene blue/ parabens on Staphylococcus aureus bacteria and biofilm, and comparison with various heparin solutions. J Antimicrob Chemother 2009; 63:937-945